FARALLON CAPITAL MANAGEMENT LLC
Q2 2023 13F-HR Holdings
Net value change ($000)
+223,483
(1.3%)
New positions
17
Sold out positions
32
Turnover %
20.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ADI | 404,231 | NEW |
| IQV | 231,150 | 36.2% |
| UNH | 195,767 | 47.8% |
| TRU | 195,287 | 36.5% |
| LNTH | 98,982 | 651.6% |
| IVERIC bio, Inc. | 84,285 | 714.6% |
| SHW | 71,466 | 24.3% |
| OPCH | 67,161 | NEW |
| WAB | 66,720 | 23.1% |
| NYT | 66,579 | 26.9% |
Top Reduces (Value $000, Stocks/ETFs)
| Horizon Therapeutics Public Ltd Co | -591,519 | -100.0% |
| SHAW COMMUNICATIONS INC | -472,755 | -100.0% |
| DT | -329,444 | -100.0% |
| CRM | -288,836 | -41.3% |
| MSFT | -187,468 | -39.0% |
| Oak Street Health, Inc. | -174,179 | -100.0% |
| Prometheus Biosciences, Inc. | -118,139 | -100.0% |
| BSX | -112,596 | -29.2% |
| ELV | -111,886 | -36.1% |
| GOOGL | -107,494 | -18.9% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,195,550
(17.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|